You are here

antitrust

Novartis, Roche avoid $475M antitrust fine in French appeals court

Fierce Pharma

Mon, 02/20/23 - 12:57 pm

Illumina Could Face Hefty Fine Over Grail Acquisition

Medical Devices and Diagnostics Industry

Mon, 01/16/23 - 11:07 am

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Thu, 01/5/23 - 09:57 am

Is CVS' Acquisition of Signify in Danger of Falling Through?

Motley Fool

Thu, 09/15/22 - 10:32 am

Illumina defeats F.T.C. in major antitrust case

NY Times, NY

Thu, 09/1/22 - 07:46 pm

After delay, CSL's $11.7B deal for Vifor poised to close next week

Fierce Pharma

Tue, 08/2/22 - 10:39 am

Can Illumina Hold on to Grail?

Medical Devices and Diagnostics Industry

Tue, 08/2/22 - 12:01 am

Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug

Fierce Pharma

Thu, 07/21/22 - 09:38 pm

Illumina loses challenge to block EU antitrust probe into $8B Grail buyout

Endpoints

Thu, 07/14/22 - 10:53 am

Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme

Fierce Pharma

Wed, 06/1/22 - 07:36 pm

As antitrust case wraps, Martin Shkreli's lawyers say they're owed $2M+ in unpaid legal fees

Endpoints

Wed, 04/13/22 - 10:32 am

AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger

Fierce Pharma

Wed, 01/26/22 - 11:00 am

Antitrust regulators aim to revamp merger guidelines, signaling threat to health sector deals

BioPharma Dive

Sat, 01/22/22 - 02:10 pm

Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case

Fierce Pharma

Sun, 01/16/22 - 03:58 am

Shkreli's former company Vyera settles for $40M in antitrust case, but 'pharma bro' still faces his own trial

Fierce Pharma

Tue, 12/7/21 - 11:46 pm

Vyera Pharmaceuticals

Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January

Fierce Pharma

Fri, 11/26/21 - 08:46 pm

Pfizer, Mylan escape another EpiPen lawsuit after judge scraps pharmacy chain's antitrust complaints

Fierce Pharma

Tue, 07/27/21 - 04:27 pm

Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit

Reuters

Fri, 07/16/21 - 11:07 am

Healthcare mergers, 'pay for delay' deals get added scrutiny under Biden order

BioPharma Dive

Sun, 07/11/21 - 10:55 pm

Pharma in the crosshairs: How the FTC is expanding its antitrust powers under its new chair

Endpoints

Fri, 07/2/21 - 11:08 am

Pages